Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Stat News

STAT+: For pancreatic cancer patients, an exciting drug can feel out of reach

STAT+: For pancreatic cancer patients, an exciting drug can feel out of reach
ShareXFacebook

For pancreatic cancer patients, the surge in interest for an exciting new drug is leaving them fearful about when they might get the treatment or if there will be enough…

S

Source

Stat News

Read full article at Stat News

Opens original article in a new tab

Advertisement

Related Health Stories

Antibiotic Combo Approved for Multidrug-Resistant UTIs
MedPage Today

Antibiotic Combo Approved for Multidrug-Resistant UTIs

(MedPage Today) -- The FDA approved intravenous cefepime and zidebactam (Zaynich) for complicated urinary tract infections (UTIs), including pyelonephritis, caused by susceptible gram-negative bacteria in adults, Wockhardt announced. The novel...

Read more →
Advertisement